Advertisement
Screener

Anteris Technologies Global Corp. (AVR) Executive Pay versus Performance: Other Disclosures

Anteris Technologies Global Corp. Other Executive Compensation Disclosures

Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.

  • 2026-08-11: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
  • 2026-08-11: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
  • 2026-08-11: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
  • 2026-08-11: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
FiledDisclosureQualifiersPeriodValue
2026-08-11
10-Q
Non Rule10b51Arr Terminated2026-04-01..2026-06-30No
2026-08-11
10-Q
Rule10b51Arr Terminated2026-04-01..2026-06-30No
2026-08-11
10-Q
Non Rule10b51Arr Adopted2026-04-01..2026-06-30No
2026-08-11
10-Q
Rule10b51Arr Adopted2026-04-01..2026-06-30No
2026-05-12
10-Q
Rule10b51Arr Terminated2026-01-01..2026-03-31No
2026-05-12
10-Q
Rule10b51Arr Adopted2026-01-01..2026-03-31No
2026-05-12
10-Q
Non Rule10b51Arr Terminated2026-01-01..2026-03-31No
2026-05-12
10-Q
Non Rule10b51Arr Adopted2026-01-01..2026-03-31No
2026-02-26
10-K
Rule10b51Arr Adopted2025-10-01..2025-12-31No
2026-02-26
10-K
Non Rule10b51Arr Adopted2025-10-01..2025-12-31No
2026-02-26
10-K
Rule10b51Arr Terminated2025-10-01..2025-12-31No
2026-02-26
10-K
Non Rule10b51Arr Terminated2025-10-01..2025-12-31No
2026-02-26
10-K
Insider Trading Policies Proc Adopted2025-10-01..2025-12-31Yes
2025-11-12
10-Q
Rule10b51Arr Terminated2025-07-01..2025-09-30No
2025-11-12
10-Q
Rule10b51Arr Adopted2025-07-01..2025-09-30No
2025-11-12
10-Q
Non Rule10b51Arr Terminated2025-07-01..2025-09-30No
2025-11-12
10-Q
Non Rule10b51Arr Adopted2025-07-01..2025-09-30No
2025-11-10
DEF 14A
Insider Trading Policies Proc Adopted2024-01-01..2024-12-31Yes
2025-11-10
DEF 14A
Award Timing MNPI Disclosure2024-01-01..2024-12-31Policies and Practices Related to the Grant of Certain Equity Awards The Compensation Committee approves equity awards granted to the NEOs on or before the grant date. The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of such e…
2025-11-10
DEF 14A
Award Timing Predetermined2024-01-01..2024-12-31Yes
2025-11-10
DEF 14A
Award Timing Method2024-01-01..2024-12-31The Compensation Committee approves equity awards granted to the NEOs on or before the grant date.
2025-11-10
DEF 14A
Award Timing How MNPI Considered2024-01-01..2024-12-31The Compensation Committee does not take material nonpublic information into account when determining the timing and terms of such equity awards, which, for our CEO, are also subject to approval by our stockholders in accordance with the requirements of the ASX. We have not timed the disclosure of m…
2025-11-10
DEF 14A
Award Timing MNPI Considered2024-01-01..2024-12-31No
2025-11-10
DEF 14A
MNPI Disclosure Timed For Compensation Val2024-01-01..2024-12-31No
2025-08-11
10-Q
Rule10b51Arr Terminated2025-04-01..2025-06-30No
2025-08-11
10-Q
Rule10b51Arr Adopted2025-04-01..2025-06-30No
2025-08-11
10-Q
Non Rule10b51Arr Terminated2025-04-01..2025-06-30No
2025-08-11
10-Q
Non Rule10b51Arr Adopted2025-04-01..2025-06-30No
2025-05-13
10-Q
Rule10b51Arr Terminated2025-01-01..2025-03-31No
2025-05-13
10-Q
Rule10b51Arr Adopted2025-01-01..2025-03-31No
2025-05-13
10-Q
Non Rule10b51Arr Terminated2025-01-01..2025-03-31No
2025-05-13
10-Q
Non Rule10b51Arr Adopted2025-01-01..2025-03-31No

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enovis CORP (ENOV)United States$1.053B-1.18
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B